CLINICAL_TRIALS
withdrawal
· 2012-08-10
Clinical Trial Update: Gemcitabine/Oxaliplatin and Photodynamic Therapy in Cholangiocarcinoma [Phase 2]
Summary
A Phase 2 trial of gemcitabine and oxaliplatin with photodynamic therapy for cholangiocarcinoma has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Technical University of Munich | Conditions: Cholangiocarcinoma | Phase 2 | Status: WITHDRAWN